Shares of Moderna (NASDAQ: MRNA) are behaving like it's 2020. The stock is up nearly 20% since the company’s Science Day event.
At that time, Moderna revealed its strategy for using mRNA to combat cancer and rare diseases. It’s a move beyond vaccines, and investors seem to like it.
